Gossamer Bio is trading at $0.18, up 5.53%, with no clear company-specific catalyst identified.
- No company-specific announcement dated August 31, 2026 was identified in the reviewed sources.
- Its latest major update was an August 21, 2026 financing announcement for up to $250 million, including $150 million in committed capital; it does not establish a same-day catalyst.
- Broader markets are lower, so the gain does not clearly align with overall market direction.